Historical record - last NADAC effective date: 2/21/2024
Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0684 per EA under NDC 69097094605. Its NADAC has been published 320 times since Jan 10, 2018.
FDA first approved this application on May 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Cipla USA Inc.NDC
69097094605
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/21/2024
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205519FDA Approved
5/19/2016
TE Code
AB
On Market Since
11/16/2017
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 320 times since Jan 10, 2018, and over the history we have for it it has declined 29.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0684 per EA |
|---|---|
| All-time high | $0.1257 (Sep 12, 2018) |
| All-time low | $0.0538 (Oct 18, 2023) |
| Median price | $0.0765 |
| Average price | $0.0792 |
| Largest weekly change | +19.7% (Jan 17, 2024) |
| Weeks tracked | 320 |
| Tracking since | Jan 10, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+19.3%
5Y
+8.8%
All
-29.1%
Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Cipla USA Inc., is $0.0684 per EA (NDC 69097094605), effective Feb 21, 2024.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 29.1%. It has been tracked across 320 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Jan 10, 2018, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0538 (Oct 18, 2023) to a high of $0.1257 (Sep 12, 2018), with a median of $0.0765 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 40 MG TABLET, is $0.0370 per EA — about 46% below ATORVASTATIN 40 MG TABLET.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 69097094605) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.